| ALL | Acute lymphoblastic leukemia |
| AML | Acute myeloid leukemia |
| BCR | B-cell antigen receptor |
| BM | Bone marrow |
| CAF | Cancer-associated fibroblast |
| CLL | Chronic lymphocytic leukemia |
| CML | Chronic myeloid leukemia |
| ECM | Extracellular matrix |
| EMT | Epithelial-mesenchymal transition |
| ESC | Embryonic stem cell |
| EV | Extracellular vesicle |
| FGF2 | Fibroblast growth factor 2 |
| FGFR2 | Fibroblast growth factor receptor 2 |
| GVHD | Graft-versus-host disease |
| HSC | Hematopoietic stem cells |
| HSCT | Hematopoietic stem cell transplantation |
| HSPC | Hematopoietic stem progenitor cell |
| LSC | Leukemia stem cell |
| MDSC | Myeloid-derived suppressor cell |
| MSC | Mesenchymal stem cell |
| PDGF | Platelet-derived growth factor |
| PTL | Parthenolide |
| rGSH | Reduced glutathione |
| ROS | Reactive oxygen species |
| TGF-β | Transforming growth factor-β |
| TKI | Tyrosine kinase inhibitor |
| TNT | Tunneling nanotube |
| USP16 | Ubiquitin-specific peptidase 16 |
| VEGF | Vascular endothelial growth factor |